The presence of p53-specific CD8+ T cell precursors in PBMCs of cancer patients and healthy individuals was reported by several groups and p53-specific CD8+ T cells have been found to specifically recognize tumor cells accumulating p53 [22], [45], [46], [47]. This evidence concerns the gene CD8A and cancer.